Cargando…
Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients
BACKGROUND: In myasthenia gravis (MG) patients, the dysfunction of CD4(+)CD25(+) regulatory T cells (CD4(+)CD25(+) Tregs) may be one of the important pathogenesis of MG. Currently, the role of IFN-γ in autoimmune diseases is still controversial and needs further exploration. In this study, whether I...
Autores principales: | Huang, Shuo, Wang, Weizhi, Chi, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562356/ https://www.ncbi.nlm.nih.gov/pubmed/26347149 http://dx.doi.org/10.1186/s12883-015-0419-9 |
Ejemplares similares
-
The potential role of cell surface complement regulators and circulating CD4+ CD25+ T-cells in the development of autoimmune myasthenia gravis
por: Hamdoon, Mohamed Nasreldin Thabit, et al.
Publicado: (2016) -
Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis
por: Chen, Pan, et al.
Publicado: (2021) -
Hepatitis B envelope antigen increases Tregs by converting CD4+CD25(-) T cells into CD4(+)CD25(+)Foxp3(+) Tregs
por: Tang, Rui, et al.
Publicado: (2020) -
Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice
por: Balasa, Balaji, et al.
Publicado: (1997) -
In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4(+)CD25(−) Cells in Mice
por: Arazi, Arnon, et al.
Publicado: (2009)